Literature DB >> 2645802

Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers.

J R Davis1, J R Murphy, D F Clyde, S Baqar, A H Cochrane, F Zavala, R S Nussenzweig.   

Abstract

Plasmodium falciparum infected Anopheles stephensi, taken from a group of mosquitoes which had been used to challenge recipients of (NANP)3-TT vaccine, were tested for P. falciparum sporozoite content by an immunoradiometric assay. Seventy-six percent were infected with mean and median sporozoite equivalents per mosquito of 220,994 and 217,398, respectively (SD = 54,911). This sporozoite density is greater than that usually found in the field. These data suggest that this challenge for evaluating P. falciparum sporozoite vaccines is a demanding test of immunity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645802     DOI: 10.4269/ajtmh.1989.40.128

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Authors:  D A Herrington; D F Clyde; J R Davis; S Baqar; J R Murphy; J F Cortese; R S Bank; E Nardin; D DiJohn; R S Nussenzweig
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy.

Authors:  J R Murphy; D F Clyde; D A Herrington; S Baqar; J R Davis; K Palmer; J Cortese
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

3.  Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.

Authors:  Philip Bejon; George Warimwe; Claire L Mackintosh; Margaret J Mackinnon; Sam M Kinyanjui; Jennifer N Musyoki; Peter C Bull; Kevin Marsh
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

4.  Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.

Authors:  L M Upton; P M Brock; T S Churcher; A C Ghani; P W Gething; M J Delves; K A Sala; D Leroy; R E Sinden; A M Blagborough
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.